Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million
04 déc. 2023 08h30 HE
|
Mycotopia Therapies Inc.
MIAMI, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (“Mycotopia Therapies”) (“the Company”) (OTC: TPIA) announced today it has purchased certain assets of Philon Labs, LLC ("Philon...
PSLY.com, Inc. Ei.Ventures, Inc. and Mycotopia Therapies Inc. Terminate Agreement and Plan of Merger
21 févr. 2023 16h37 HE
|
Mycotopia Therapies Inc.
MIAMI and MAUI, Hawaii, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Ei.Ventures, Inc. (Ei.Ventures) and Mycotopia Therapies Inc. (“Mycotopia Therapies”)(OTC: TPIA) announced today that on February 16,...
Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction
19 mai 2022 12h07 HE
|
Mycotopia Therapies Inc.
MIAMI and MAUI, Hawaii, May 19, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of...
Mycotopia Therapies Inc. Update on Ei.Ventures and Strategic Investments
09 mai 2022 08h30 HE
|
Mycotopia Therapies Inc.
MIAMI, May 09, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA), a biopharma company focused on research, technology, and the development of medical psychedelics, and Ei.Ventures...
Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market
02 mai 2022 08h30 HE
|
Mycotopia Therapies Inc.
MIAMI, May 02, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products
21 mars 2022 08h30 HE
|
Mycotopia Therapies Inc.
MIAMI, March 21, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc.
17 mars 2022 08h51 HE
|
Mycotopia Therapies Inc.
MIAMI, March 17, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia Therapies Announces Ei.Ventures Acquires 12x12 Estate in The Sandbox in Anticipation of PSLY.COM Launch Post-Merger with Mycotopia Therapies in Q1 2022
06 janv. 2022 10h30 HE
|
Mycotopia Therapies Inc.
MIAMI, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia and Ei.Ventures sign LOI to Explore Merger and Formation of PSLY.COM, a $360 Million Transaction, And Will Apply To List Shares On NASDAQ
07 déc. 2021 15h03 HE
|
Mycotopia Therapies Inc.
MIAMI, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia Therapies Announces Plan to Develop Psychedelic Sublingual Tablet to Help Treat Depression
17 nov. 2021 08h30 HE
|
Mycotopia Therapies Inc.
MIAMI, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...